Achilles Historical Balance Sheet

ACHL Stock

USD 1.06 0.01 0.93%

Trend analysis of Achilles Therapeutics PLC balance sheet accounts such as Total Current Liabilities of 13.9 M, Net Tangible Assets of 173.7 M or Accounts Payable of 4 M provides information on Achilles Therapeutics' total assets, liabilities, and equity, which is the actual value of Achilles Therapeutics PLC to its prevalent stockholders. By breaking down trends over time using Achilles Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Achilles Therapeutics PLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Achilles Therapeutics PLC is a good buy for the upcoming year.

Achilles Therapeutics Inventory

0.95

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

About Achilles Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Achilles Therapeutics PLC at a specified time, usually calculated after every quarter, six months, or one year. Achilles Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Achilles Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Achilles currently owns. An asset can also be divided into two categories, current and non-current.

Achilles Therapeutics Balance Sheet Chart

At this time, Achilles Therapeutics' Property Plant And Equipment Net is quite stable compared to the past year. Cash is expected to rise to about 186.3 M this year, although the value of Total Current Liabilities will most likely fall to about 13.9 M.

Other Current Liab Total Current Liabilities Net Tangible Assets Accounts Payable Total Current Assets Capital Lease Obligations

Total Current Liabilities

Total Current Liabilities is an item on Achilles Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Achilles Therapeutics PLC are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Accounts Payable

An accounting item on the balance sheet that represents Achilles Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Achilles Therapeutics PLC are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Capital Lease Obligations

Achilles Therapeutics PLC capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Achilles Therapeutics asset purchases. For example, Achilles Therapeutics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Achilles Therapeutics control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.

Most accounts from Achilles Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Achilles Therapeutics PLC current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

	2021	2022	2023	2024 (projected)
Total Current Liabilities	19.1M	18.0M	17.0M	13.9M
Other Current Liabilities	10.9M	8.3M	7.8M	6.3M

Total Current Liabilities Other Current Liab

Achilles Therapeutics balance sheet Correlations

	Other Current Liab	Total Current Liabilities	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Other Current Assets	Other Stockholder Equity	Total Current Assets	Property Plant Equipment	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Inventory
Other Current Liab		0.99	0.98	-0.81	0.91	0.93	0.95	0.97	0.96	0.97	0.94	0.87	0.93	0.94	-0.1	-0.9	0.92	0.95	0.98	0.92	0.96	0.93	-0.39	0.69	0.87	0.7
Total Current Liabilities	0.99		0.98	-0.83	0.96	0.94	0.92	0.98	0.96	0.98	0.91	0.89	0.89	0.95	-0.17	-0.84	0.88	0.95	0.98	0.88	0.97	0.97	-0.42	0.72	0.89	0.64
Net Tangible Assets	0.98	0.98		-0.8	0.91	0.9	0.91	0.97	0.98	0.96	0.91	0.85	0.9	0.92	-0.08	-0.87	0.89	0.92	0.95	0.89	0.94	0.91	-0.4	0.68	0.85	0.64
Retained Earnings	-0.81	-0.83	-0.8		-0.81	-0.85	-0.78	-0.89	-0.72	-0.76	-0.66	-0.58	-0.64	-0.67	0.61	0.5	-0.61	-0.69	-0.78	-0.61	-0.85	-0.86	0.77	-0.23	-0.58	-0.27
Accounts Payable	0.91	0.96	0.91	-0.81		0.87	0.8	0.92	0.87	0.96	0.79	0.88	0.75	0.9	-0.27	-0.69	0.74	0.91	0.93	0.74	0.97	0.99	-0.44	0.73	0.88	0.48
Net Receivables	0.93	0.94	0.9	-0.85	0.87		0.96	0.96	0.89	0.86	0.83	0.75	0.82	0.83	-0.37	-0.76	0.79	0.84	0.91	0.79	0.89	0.9	-0.38	0.53	0.75	0.7
Other Current Assets	0.95	0.92	0.91	-0.78	0.8	0.96		0.94	0.92	0.87	0.92	0.78	0.92	0.87	-0.16	-0.89	0.9	0.88	0.93	0.9	0.86	0.85	-0.31	0.58	0.78	0.82
Other Stockholder Equity	0.97	0.98	0.97	-0.89	0.92	0.96	0.94		0.94	0.93	0.86	0.78	0.84	0.86	-0.28	-0.79	0.82	0.88	0.93	0.82	0.96	0.93	-0.46	0.56	0.78	0.61
Total Current Assets	0.96	0.96	0.98	-0.72	0.87	0.89	0.92	0.94		0.94	0.96	0.89	0.95	0.95	0.01	-0.91	0.94	0.95	0.96	0.94	0.88	0.87	-0.34	0.73	0.89	0.72
Property Plant Equipment	0.97	0.98	0.96	-0.76	0.96	0.86	0.87	0.93	0.94		0.92	0.93	0.89	0.97	-0.04	-0.86	0.89	0.97	0.98	0.89	0.97	0.96	-0.37	0.8	0.93	0.61
Total Assets	0.94	0.91	0.91	-0.66	0.79	0.83	0.92	0.86	0.96	0.92		0.91	1.0	0.96	0.11	-0.96	1.0	0.96	0.96	1.0	0.82	0.82	-0.33	0.75	0.91	0.76
Short Long Term Debt Total	0.87	0.89	0.85	-0.58	0.88	0.75	0.78	0.78	0.89	0.93	0.91		0.89	0.98	0.11	-0.84	0.89	0.98	0.94	0.89	0.83	0.88	-0.29	0.91	1.0	0.62
Total Stockholder Equity	0.93	0.89	0.9	-0.64	0.75	0.82	0.92	0.84	0.95	0.89	1.0	0.89		0.94	0.14	-0.97	1.0	0.95	0.94	1.0	0.79	0.79	-0.31	0.73	0.89	0.78
Property Plant And Equipment Net	0.94	0.95	0.92	-0.67	0.9	0.83	0.87	0.86	0.95	0.97	0.96	0.98	0.94		0.05	-0.89	0.94	1.0	0.98	0.94	0.88	0.91	-0.34	0.85	0.98	0.68
Current Deferred Revenue	-0.1	-0.17	-0.08	0.61	-0.27	-0.37	-0.16	-0.28	0.01	-0.04	0.11	0.11	0.14	0.05		-0.31	0.18	0.03	-0.1	0.18	-0.24	-0.31	0.59	0.39	0.11	0.26
Net Debt	-0.9	-0.84	-0.87	0.5	-0.69	-0.76	-0.89	-0.79	-0.91	-0.86	-0.96	-0.84	-0.97	-0.89	-0.31		-0.97	-0.89	-0.88	-0.97	-0.75	-0.71	0.09	-0.76	-0.84	-0.86
Cash	0.92	0.88	0.89	-0.61	0.74	0.79	0.9	0.82	0.94	0.89	1.0	0.89	1.0	0.94	0.18	-0.97		0.94	0.93	1.0	0.78	0.77	-0.3	0.74	0.89	0.77
Non Current Assets Total	0.95	0.95	0.92	-0.69	0.91	0.84	0.88	0.88	0.95	0.97	0.96	0.98	0.95	1.0	0.03	-0.89	0.94		0.99	0.94	0.89	0.92	-0.35	0.84	0.98	0.68
Non Currrent Assets Other	0.98	0.98	0.95	-0.78	0.93	0.91	0.93	0.93	0.96	0.98	0.96	0.94	0.94	0.98	-0.1	-0.88	0.93	0.99		0.93	0.94	0.95	-0.4	0.76	0.94	0.68
Cash And Short Term Investments	0.92	0.88	0.89	-0.61	0.74	0.79	0.9	0.82	0.94	0.89	1.0	0.89	1.0	0.94	0.18	-0.97	1.0	0.94	0.93		0.78	0.77	-0.3	0.74	0.89	0.77
Common Stock Total Equity	0.96	0.97	0.94	-0.85	0.97	0.89	0.86	0.96	0.88	0.97	0.82	0.83	0.79	0.88	-0.24	-0.75	0.78	0.89	0.94	0.78		0.97	-0.43	0.66	0.83	0.53
Common Stock Shares Outstanding	0.93	0.97	0.91	-0.86	0.99	0.9	0.85	0.93	0.87	0.96	0.82	0.88	0.79	0.91	-0.31	-0.71	0.77	0.92	0.95	0.77	0.97		-0.49	0.69	0.88	0.5
Short Term Investments	-0.39	-0.42	-0.4	0.77	-0.44	-0.38	-0.31	-0.46	-0.34	-0.37	-0.33	-0.29	-0.31	-0.34	0.59	0.09	-0.3	-0.35	-0.4	-0.3	-0.43	-0.49		0.11	-0.29	0.27
Non Current Liabilities Total	0.69	0.72	0.68	-0.23	0.73	0.53	0.58	0.56	0.73	0.8	0.75	0.91	0.73	0.85	0.39	-0.76	0.74	0.84	0.76	0.74	0.66	0.69	0.11		0.91	0.64
Capital Lease Obligations	0.87	0.89	0.85	-0.58	0.88	0.75	0.78	0.78	0.89	0.93	0.91	1.0	0.89	0.98	0.11	-0.84	0.89	0.98	0.94	0.89	0.83	0.88	-0.29	0.91		0.62
Inventory	0.7	0.64	0.64	-0.27	0.48	0.7	0.82	0.61	0.72	0.61	0.76	0.62	0.78	0.68	0.26	-0.86	0.77	0.68	0.68	0.77	0.53	0.5	0.27	0.64	0.62

Click cells to compare fundamentals

Achilles Therapeutics Account Relationship Matchups

Achilles Therapeutics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	681K	6.6M	10.9M	8.3M	7.8M	6.3M
Total Current Liabilities	3.9M	16.6M	19.1M	18.0M	17.0M	13.9M
Net Tangible Assets	101.3M	189.2M	289.5M	197.0M	226.6M	173.7M
Retained Earnings	(24.8M)	(58.0M)	(119.1M)	(190.3M)	(260.0M)	(247.0M)
Accounts Payable	902K	6.3M	3.7M	5.2M	5.6M	4.0M
Net Receivables	4.5M	7.3M	11.2M	16.0M	10.4M	9.5M
Other Current Assets	477K	2.6M	7.3M	7.2M	3.7M	4.0M
Other Stockholder Equity	118.0M	234.9M	401.9M	409.0M	415.2M	289.4M
Total Current Assets	103.1M	187.8M	284.7M	196.6M	145.6M	170.7M
Property Plant Equipment	2.1M	28.1M	28.8M	20.5M	23.6M	17.6M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Achilles Therapeutics PLC is a strong investment it is important to analyze Achilles Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Achilles Therapeutics' future performance. For an informed investment choice regarding Achilles Stock, refer to the following important reports:

How To Invest In Achilles

Details

Is Achilles Stock a good investment?

Details

What is Achilles Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achilles Therapeutics. If investors know Achilles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achilles Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.66)

Return On Assets

(0.27)

Return On Equity

(0.44)

The market value of Achilles Therapeutics PLC is measured differently than its book value, which is the value of Achilles that is recorded on the company's balance sheet. Investors also form their own opinion of Achilles Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Achilles Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achilles Therapeutics' market value can be influenced by many factors that don't directly affect Achilles Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Achilles Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Achilles Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achilles Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Achilles Historical Balance Sheet

Achilles Therapeutics Inventory

0.95

About Achilles Balance Sheet Analysis

Achilles Therapeutics Balance Sheet Chart

Total Current Liabilities

Net Tangible Assets

Accounts Payable

Total Current Assets

Capital Lease Obligations

Achilles Therapeutics balance sheet Correlations

Achilles Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Achilles Therapeutics balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Capital Lease Obligations	+ 1.0	Short Long Term Debt Total
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity

Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Net Debt	- 0.97	Total Stockholder Equity
Net Debt	- 0.96	Total Assets
Net Debt	- 0.91	Total Current Assets
Net Debt	- 0.9	Other Current Liab